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Abstract: The rs1800629 polymorphism plays a crucial role in the pathogenesis of 
infectious and autoimmune diseases. Meanwhile, tuberculosis (TB) remains a health 
primary infectious disease in Indonesia. The purpose of this study is to evaluate the HRM 
method in detecting the rs1800629 genotype, in the TNF-α gene’s promoter region, within 
TB patients. The benefit of this study is to accelerate the detection of rs1800629 with a 
simple, rapid, and cost-effective method for genotyping and mutation screening that does 
not include the use of a fluorescent probe. In this experimental study, the rs1800629 
genotyped in a total of 25 tuberculosis patients using KAPA HRM kit in MyGo Mini PCR, 
and all amplified PCR products subsequently dispatched for direct DNA sequencing to 
Macrogen Inc, South Korea. Based on the results, a 100% concordance find in the 
genotyping of rs1800629 between HRM and sequencing. The authors provided evidence 
to use HRM in detecting rs1800629 within the TNF-α promotor region. This application 
as a genotyping assay in tuberculosis patients is a low-cost, rapid, and accurate 
detection. However, further studies using the HRM method in case-control samples of 
tuberculosis are required to evaluate the method’s effectiveness and to obtain more 
information regarding the genotype’s susceptibility to tuberculosis and its adverse effect 
treatment, including anti-tuberculosis drug, induced liver injury (AT-DILI), and multidrug-
resistant TB (MDR-TB), within the Indonesian population.   
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INTRODUCTION 
 Tumor necrosis factor-alpha (TNF-α) is a human leukocyte antigen system gene 
located on the 6p21 chromosome, in the class III region major histocompatibility complex 
(Yang et al., 2014; Aboutorabi et al., 2018). However, the most studied polymorphism is 
TNF-α (-308 A/G) rs1800629, found in the promoter region. The transition from G to A 
within the promoter at position -308 is associated with the TNF-α levels (Elahi et al., 2009; 
Li et al., 2013). Alteration in these levels has a possible influence on the immune response 
to pathogens and a contribution to disease susceptibility in individuals (Elahi et al., 2009; 
Qidwai and Khan, 2011).  
 In addition, the rs1800629 polymorphism has a crucial role in infectious and 
autoimmune disease pathogenesis (Qidwai and Khan, 2011). According to previous 
studies show that these polymorphism are associated with asthma (Yang et al., 2014), 
Medical Laboratory Technology Journal  
 
 Available online at : http://ejurnal-analiskesehatan.web.id 
ISSN 2461-0879 
 




7(1), 2021, 66-72 
Medical Laboratory Technology Journal | 67 
 
Copyright © 2021, MLTJ, ISSN 2461-0879 
Osteoarthritis (Chen et al., 2018), celiac disease (Khan et al., 2016), and infectious 
diseases, including leprosy and tuberculosis (Qidwai and Khan, 2011). Tuberculosis 
remains a significant contagious disease globally, and Indonesia is known as the country 
with the second-highest TB cases (World Health Organization (WHO), 2020). A previous 
study showed an association between rs1800629 and tuberculosis (Wu et al., 2019), but 
another study showed a contrary result (Qidwai and Khan, 2011). However, these 
polymorphisms are worth studying because a different study reported rs1800629 to 
significantly correlated with anti-tuberculosis drug induced liver injury (AT-DILI) (Kim et 
al., 2012), the most prevalent adverse reaction in tuberculosis treatment (Chen et al., 
2015). Due to rs1800629’s important role, there is a need to develop a reliable and low-
cost technique to detect the polymorphism. 
 The HRM (High-resolution melting curve) analysis is a potential method for rapid 
genotyping and a high-throughput technique for conducting genetic variation screening 
and scanning for mutation in disease-related genes, using the double-stranded DNA’s 
melting profile (Chen et al., 2014; Islam et al., 2018). In addition, the technique uses a 
fluorescent DNA binding dye for genotyping, as opposed to expensive labeled probes. In 
the presence of saturated DNA binding dye concentrations, a reduction in fluorescence 
intensity occurs as the double-stranded DNA becomes single stranded, following a 
temperature rise and dye release (Graham et al., 2005). The HRM analysis allows 
researchers to detect and locate mutations rapidly and identify novel genetic variants 
without any post-PCR handling, for instance, sequencing or electrophoresis (Islam et al., 
2018).  
 To the best of our knowledge, no published study evaluates the HRM analysis to 
detect rs1800629 for TB patient screening. Additionally, another method, such as 
Taqman genotyping assay, is expensive. Another way, such as combining conventional 
PCR and DNA sequencing as a standard gold method for SNP genotyping, is more 
laborious and time-consuming. Therefore, this study evaluates the HRM technique’s 
effectiveness in detecting rs1800629 polymorphism within the TNF alpha gene in TB 
patients, which can apply in clinical settings. 
 
MATERIALS AND METHOD 
Sample Collection 
 This is an experimental study involving 25 tuberculosis patients from Pasar Rebo 
Hospital, Jakarta, Indonesia. Before the experiment, all participants filled and submitted 
consent forms. Subsequently, 3 mL of peripheral venous blood collects with EDTA as an 
anticoagulant (BD Vacutainer) and stored in a − 20 °C freezer until further processing.  
DNA Extraction 
 Genomic DNA extracted with a Maxwell RSC Whole Blood DNA kit (Promega) in 
Maxwell automatic nucleic acid instrument (Promega) according to the manufacturer’s 
instructions from each blood sample, The quantity, and quality of DNA then calculated 
using NanoQuant Plate (Tecan) before amplification and HRM analysis.   
Amplification and HRM Analysis 
 The rs1800629 variants were amplified in a MyGo Mini Real-Time PCR System 
(MyGoPCR). A 20 μl total volume PCR reaction mixture was prepared by adding ten μl 
KAPA HRM Master Mix, one μl of 10 ng genomic DNA, 0.6 μl of 10 μM forward primer 
and 0.6 μl of 10 μM reverse primers, two μl of MgCl2 (KAPA HRM Fast, KAPA BioSystem) 
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and 5.8 μl of Nucleus Free Water (NFW). Furthermore, the PCR thermocycling profile 
included one cycle denaturation at 95°C for 5 min, 45 cycles denaturation at 95°C for 10 
s, annealing and extension at 60°C for 30 s, and an HRM step from 60°C to 95°C, rising 
at 0.2°C. Also, forward and reverse primer selection was performed using the Primer3 
software (CA, USA), synthesized by Macrogen Inc. (South Korea). The primer sequences 
were 308F3: 5’-CACAGACCTGGTCCCCAAAA-3’ and 308R5: 5’-
CATCCTCCCTGCTCCGATTC-3’, and the primers targeted the TNF-α gene’s 136 bp 
long, near the rs1800629 variant. 
 The HRM data analysis conducts with the MyGo Mini PCR software supplied with 
the instrument and distinguishing sequence variations based on different normalized and 
temperature-shifted melting curve shapes. Sequencing analyses were also conducted in 
all 25 samples to confirm the HRM assay genotyping data’s quality and accuracy. In 
addition, purification of HRM amplicons was carried out with a gel purification kit before 
dispatch for direct DNA Sequence by Macrogen Inc., South Korea. This study received 
approval from YARSI University’s Ethics Committees, with 049/KEP-UY/BIA/V/2020. 
 
RESULTS AND DISCUSSION 
 Based on the previous study, rs1800629 in the TNF-α promoter region is 
associated with autoimmune and infectious disease, including asthma (Yang et al., 2014), 
Osteoarthritis (Chen et al., 2018), celiac disease (Khan et al., 2016), and infectious 
disease, such as leprosy and tuberculosis (Qidwai and Khan, 2011). Currently, 
tuberculosis and adverse effect treatments are a significant problem in Indonesia (World 
Health Organization(WHO), 2020). In the inflammatory response against tuberculosis, 
TNF-α acts as an essential mediator (Sivangala et al., 2014). The antigen system gene 
also plays a critical role in drug-induced immune responses, with a possible influence on 
AT-DILI incidence (anti-tuberculosis drug-induced liver injury) (Bao et al., 2018).  
 A previous study showed rs1800620 and association to tuberculosis is inconsistent 
within the population. Wu et al. (2019) reported rs1800629 associated with tuberculosis 
in the Tibetan but not in the Han Chinese population (Wu et al., 2019). Meanwhile, 
Bikmaeva et al. (2002) showed an association between the ‘A’ allele and risk of 
pulmonary tuberculosis within the Russian population (Bikmaeva et al., 2002). Scola et 
al. (2003) reported reduced low-producer GG homozygous individuals in Caucasian TB 
patients (Scola et al., 2003). However, several studies stated no association between 
rs1800629 and risk of tuberculosis within the Southern and Northern Indian populations 
and Thai and Turkish people (Qidwai and Khan, 2011; Sivangala et al., 2014). Thus, there 
is a need to develop a reliable and low-cost technique to detect polymorphism, 
considering rs1800629’s crucial role. 
 According to Figure 1, three genotypes for TNF-α rs1800629 SNP were 
distinguished. The homozygote GG’s Tm value (approximately 87.5°C) experienced a left 
shift compared to the homozygote AA (86°C) due to the GC base pair present a higher 
melting temperature, compared to the AT base pair. Furthermore, the heterozygote AG’s 
temperature-shifted melting peak occurred between homozygotes AA and GG (87°C). 
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Figure 1. Normalized graphs for HRM of rs1800629. 
 
 The primer in this study successfully detected the rs1800629 genotype. Primer 
design, reaction components, and cycling conditions are critical components of a 
successful HRM assay (Tucker and Huynh, 2014). In this study, the primer designed to 
target the PCR product 136 bp, from TNF-α gene amplification, and the product size are 
sufficient for HRM assay based on Tucker & Huynh, 2014. A PCR product above 500 bp 
decreases the sensitivity and makes analysis difficult due to gradual melting and variant 
detection disruption (Słomka et al., 2017). However, several studies suggested an 
amplicon size below 100 bp allows for increased analysis accuracy. The reduction in 
amplicon results in increased melting temperature differences, and consequently, 
improved differentiation (Erali, Voelkerding, and Wittwer, 2008; Słomka et al., 2017). 
 Figure 2 shows the TNF-α rs1800629 polymorphism’s sequencing result. Direct 
DNA sequencing as a gold standard for SNP genotyping showed representing rs1800629 
GG and AA genotypes. All the 25 samples used to optimize the HRM method showed 
concordance results between HRM and sequencing results. A 100% concordance 
observed while comparing rs1800629 HRM genotyping to the effects of DNA sequencing. 
This result proved HRM method could detect and differentiate genotype in rs1800629. 
Therefore, this low-cost, easy, and high sensitivity/ specificity technology ought to apply 
in detecting other variants within the TNF-α gene. A previous study showed that 
discordance results between HRM and Sanger sequencing methods could be found due 
to low-quality DNA samples (Do and Dobrovic, 2009). Low-quality DNA may produce 
nonspecific PCR products, resulting in incorrect scoring of results in HRM analyses, or 
failed reactions that also affected validation result using Sanger Sequencing (Applied 
Biosystem, 2010) 
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Figure 2. Different rs1800629 Polymorphism Genotypes from Sequencing Result (A 
representing GG genotype; B representing AG genotype; C representing AA genotype) 
 
 The HRM assay presents several benefits compared to other molecular methods. 
Firstly, the technique is fast and straightforward, as the melting analysis and amplification, 
and melting analysis are performed as one procedure, on a real-time PCR device, in this 
case, a MyGo Mini PCR system. Secondly, the potential risk of cross-contamination 
reduces because this assay conduct in one closed tube. Lastly, there is no need for 
expensive specialized reagents or fluorescent probes. In addition, no post PCR handling 
is required, including electrophoresis and sequencing.  
 However, this study faced several limitations. First, This study only uses 25 
samples to evaluate the use of the HRM method in detecting rs1800629. Therefore, 
further studies involving more models are required to examine the differences of 
genotypes in rs1800629, using the HRM method. A case-control study using the HRM 
method in tuberculosis cases is also necessary to evaluate the method’s effectiveness 
and obtain more information on rs1800629 susceptibility to tuberculosis and tuberculosis 
adverse effect treatment, including AT-DILI and MDR-TB, in the Indonesian population. 
Second, HRM analysis is not suitable for amplicons containing two or more SNPs. The 
sensitivity of mutation scanning may decrease by producing complex melting curve data, 
and a different genotyping strategy had to be applied. Therefore, it is crucial to design a 
suitable primer with optimum length. Third, although HRM analysis is rapid and cost-
effective, Sanger sequencing may be required to confirm the variants from samples that 
failed to detect using HRM analysis. 
 
CONCLUSION 
 This study provided evidence to use the HRM method in detecting rs1800629 
genotype within the TNF-α promotor region. According to the study, applying HRM as a 
genotyping assay in tuberculosis patients to detect rs1800629 genotype is a low-cost, 
rapid, and accurate technique. Further study with larger samples needs to examine the 
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differences of genotypes in rs1800629 using the HRM method to test for sensitivity and 
specificity before being applied in clinical settings. 
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